Home/NeuroTrauma Sciences/Tom Parry, PhD, MBA
TP

Tom Parry, PhD, MBA

Chief Scientific Officer

NeuroTrauma Sciences

Therapeutic Areas

NeuroTrauma Sciences Pipeline

DrugIndicationPhase
NTS-104Acute Ischemic Stroke (AIS)Phase 1